Developer docs
API playgroundTry for free, no card

Search company profiles

Kalorama Information

Full company profile

uuid000m7pc

Namestring
Kalorama Information
Legal namestring
Kalorama Information
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Kalorama Information, a brand of the Science and Medicine Group operating under parent Science and Medicine Group since 1998, is a specialist market intelligence and research firm focused on in vitro diagnostics (IVD) and adjacent life sciences verticals. Headquartered at 671 North Glebe Road, Arlington, Virginia, the firm sells syndicated market research reports priced between $5,600 and $10,000 depending on scope — including flagship titles such as the 30-Country IVD Market Atlas and the In Vitro Diagnostics Business Outlook — alongside proprietary database products (MasterFile Installed Base and ServiceTrak) and a broad suite of consulting/advisory solutions covering go-to-market strategy, pricing, competitive assessment, branding, and customer insights. Coverage spans 18 IVD segments across 30 countries, including the US, major European markets, China, Japan, India, Saudi Arabia, Vietnam, and Turkey.

The underlying technology is a content-and-data platform built around proprietary databases that track diagnostic instrument installed bases and service-and-satisfaction metrics, combined with analyst-produced reports and bespoke research. Distribution is direct-to-enterprise through the parent group's website (transparent pricing on syndicated reports) and a consultative sales motion for custom engagements. The customer base comprises IVD manufacturers, life-sciences/diagnostics corporates (with named logos including Beckman Coulter, Bio-Rad, Corning, and Illumina), and investors and healthcare stakeholders requiring market sizing and competitive intelligence for strategic and investment decisions.

Revenue mechanics combine one-time license sales of syndicated reports with higher-margin custom research and consulting engagements, supplemented by the MasterFile and ServiceTrak data assets that approximate recurring database access revenue. The company is privately held as a brand within a diversified publishing group (Science and Medicine Group) that also operates adjacent healthcare information brands such as AuntMinnie, IBO, IMV, SDI, and BioInformatics, positioning Kalorama as the specialized IVD-focused intelligence arm of that larger portfolio.

Short descriptiontext

Kalorama Information, a brand of Science and Medicine Group founded in 1998, is a specialist market intelligence firm producing syndicated reports, proprietary databases (MasterFile, ServiceTrak), and custom research for IVD manufacturers, genomics firms, life-sciences corporates, investors, and healthcare stakeholders across 30 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersArlington, United States
HQ citystring
Arlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
market research services, life sciences intelligence, diagnostics market reports, healthcare market analysis, IVD market research
Industry2 codes
SECONDARYBPAHALAE
Industry & Sector Research (Syndicated/Custom)
SECONDARYMPAAALAB
Syndicated Market Research (Panels, Omnibus, Tracker Studies)
NAICS code2 codes
  • Marketing Research and Public Opinion Polling541910
  • Marketing Research and Public Opinion Polling54191
Product category
Healthcare Market Intelligence / Life Sciences Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Syndicated Market Reports
TypeOne Time License
Description

Sale of published market research reports covering IVD markets, biotechnology, medical devices, and pharmaceuticals. Reports are priced at $5,600-$10,000 depending on scope and depth. One-time purchase model with instant digital access.

scienceandmedicinegroup.com
2Custom Market Research
TypeProfessional Services
Description

Bespoke research engagements tailored to specific client needs, including market sizing, competitive assessment, and strategic consulting services.

scienceandmedicinegroup.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Syndicated Market Reports - Tiered by geographic scope
ModelUnit PricingBilling cadencePay-as-you-go
Notes

30-Country IVD Market Atlas: $5,600-$8,000. In Vitro Diagnostics Business Outlook: $7,000-$10,000. Price varies by report depth and geographic coverage.

scienceandmedicinegroup.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kalorama Information publishes and sells syndicated market research reports covering in vitro diagnostics (IVD), medical devices, biotechnology, and pharmaceuticals, priced between $5,600 and $10,000 each. It also delivers bespoke custom market research engagements and operates proprietary databases (MasterFile Installed Base, ServiceTrak) for diagnostic equipment market intelligence, targeting IVD manufacturers, healthcare investors, and healthcare stakeholders globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 5-year market forecasts for IVD segments across 30 countries
+1 more record
Product overview1 text field

Kalorama Information, a brand of Science and Medicine Group, operates as a market intelligence and research firm specializing in life sciences. The portfolio consists of syndicated market reports (including In Vitro Diagnostics Business Outlook, 30-Country IVD Market Atlas, and Target Enrichment and Library Preparation for NGS reports), database products (MasterFile Installed Base), and consulting solutions (ServiceTrak, Custom Market Research, and strategic advisory services including Go to Market Strategy, Growth Opportunities, Market Landscape, Pricing Strategy, Product Development, Value Proposition, Branding, Competitive Assessment, and Customer Insights). The core offering centers on IVD and diagnostics market intelligence reports, supplemented by custom research services and strategic consulting solutions for top IVD manufacturers, investors, and healthcare stakeholders.

Product and service16 records
1Custom Market Research
CategoryService
Description

Tailored market research services designed to address specific business questions and strategic needs of clients in the life sciences and healthcare sectors, including market sizing, competitive assessment, and strategic consulting.

2Market Reports
CategorySyndicated Report
Description

Syndicated market intelligence reports providing industry analysis, market sizing, segmentation, and competitive insights across IVD, medical devices, biotechnology, and pharmaceuticals sectors, priced $5,600–$10,000.

3MasterFile Installed Base Database
CategoryDatabase Product
Description

Proprietary database tracking the installed base of laboratory and diagnostic equipment, providing detailed information on instrument placements and market penetration across healthcare facilities.

4ServiceTrak
CategoryService Offering
Description

Modality-specific service and satisfaction tracking for diagnostic instruments and equipment, providing insights into service contracts, maintenance, and support operations.

5In Vitro Diagnostics Business Outlook, 2026
CategorySyndicated Report
Description

Annual syndicated market outlook report for the in vitro diagnostics industry covering disease detection, health monitoring, and treatment guidance applications.

630-Country IVD Market Atlas, 2026
CategorySyndicated Report
Description

Comprehensive syndicated analysis of in vitro diagnostic markets across 30 key countries with detailed market sizing and 5-year forecasts tracking 18 IVD segments.

7Target Enrichment and Library Preparation for Next-Generation Sequencing, 2026
CategorySyndicated Report
Description

Syndicated market report sizing the global NGS library preparation and target enrichment market through 2030, with competitive share estimates and profiles of leading suppliers.

8Go to Market Strategy
CategoryConsulting Solution
Description

Strategic consulting service helping clients develop comprehensive market entry and expansion strategies supported by thorough market research.

9Growth Opportunities
CategoryConsulting Solution
Description

Advisory service leveraging market research insights to identify and pursue growth opportunities within the life sciences and healthcare markets.

10Market Landscape
CategoryConsulting Solution
Description

Analysis service providing essential market insights beyond extrapolated data to enhance projections and strategic decision-making.

11Pricing Strategy
CategoryConsulting Solution
Description

Market research-driven pricing strategy service balancing profitability and perceived value for clients.

12Product Development
CategoryConsulting Solution
Description

Strategic advisory service helping clients overcome product development hurdles and stay ahead of competitors using market research insights.

13Value Proposition
CategoryConsulting Solution
Description

Service helping clients create compelling value propositions by understanding customer needs, preferences, and pain points through market research.

14Branding
CategoryConsulting Solution
Description

Brand perception measurement service helping clients understand and measure intangible brand perceptions across diverse consumer segments for effective positioning.

15Competitive Assessment
CategoryConsulting Solution
Description

Analysis service providing insights into competitors' strategies, market positioning, and customer perceptions to identify differentiation opportunities.

16Customer Insights
CategoryConsulting Solution
Description

Feedback gathering service to drive informed decision-making and business success through essential customer feedback collection.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kalorama Information

Healthcare Market Intelligence / Life Sciences Researchkaloramainformation.com

Kalorama Information, a brand of Science and Medicine Group founded in 1998, is a specialist market intelligence firm producing syndicated reports, proprietary databases (MasterFile, ServiceTrak), and custom research for IVD manufacturers, genomics firms, life-sciences corporates, investors, and healthcare stakeholders across 30 countries.

What Kalorama Information does

Kalorama Information, a brand of the Science and Medicine Group operating under parent Science and Medicine Group since 1998, is a specialist market intelligence and research firm focused on in vitro diagnostics (IVD) and adjacent life sciences verticals. Headquartered at 671 North Glebe Road, Arlington, Virginia, the firm sells syndicated market research reports priced between $5,600 and $10,000 depending on scope — including flagship titles such as the 30-Country IVD Market Atlas and the In Vitro Diagnostics Business Outlook — alongside proprietary database products (MasterFile Installed Base and ServiceTrak) and a broad suite of consulting/advisory solutions covering go-to-market strategy, pricing, competitive assessment, branding, and customer insights. Coverage spans 18 IVD segments across 30 countries, including the US, major European markets, China, Japan, India, Saudi Arabia, Vietnam, and Turkey.

The underlying technology is a content-and-data platform built around proprietary databases that track diagnostic instrument installed bases and service-and-satisfaction metrics, combined with analyst-produced reports and bespoke research. Distribution is direct-to-enterprise through the parent group's website (transparent pricing on syndicated reports) and a consultative sales motion for custom engagements. The customer base comprises IVD manufacturers, life-sciences/diagnostics corporates (with named logos including Beckman Coulter, Bio-Rad, Corning, and Illumina), and investors and healthcare stakeholders requiring market sizing and competitive intelligence for strategic and investment decisions.

Revenue mechanics combine one-time license sales of syndicated reports with higher-margin custom research and consulting engagements, supplemented by the MasterFile and ServiceTrak data assets that approximate recurring database access revenue. The company is privately held as a brand within a diversified publishing group (Science and Medicine Group) that also operates adjacent healthcare information brands such as AuntMinnie, IBO, IMV, SDI, and BioInformatics, positioning Kalorama as the specialized IVD-focused intelligence arm of that larger portfolio.

Kalorama Information firmographics

Firmographics
Name
Kalorama Information
Legal name
Kalorama Information
Website
https://kaloramainformation.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
Kalorama Information, a brand of Science and Medicine Group founded in 1998, is a specialist market intelligence firm producing syndicated reports, proprietary databases (MasterFile, ServiceTrak), and custom research for IVD manufacturers, genomics firms, life-sciences corporates, investors, and healthcare stakeholders across 30 countries.
Ownership category
akta.pro rank

Where Kalorama Information is headquartered

Location

Headquarters

HQ city
Arlington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Kalorama Information business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Syndicated Market Reports: Sale of published market research reports covering IVD markets, biotechnology, medical devices, and pharmaceuticals. Reports are priced at $5,600-$10,000 depending on scope and depth. One-time purchase model with instant digital access.
  2. Custom Market Research: Bespoke research engagements tailored to specific client needs, including market sizing, competitive assessment, and strategic consulting services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSyndicated Market Reports - Tiered by geographic scope

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Kalorama Information product offering

Product offering

Core offering

Kalorama Information publishes and sells syndicated market research reports covering in vitro diagnostics (IVD), medical devices, biotechnology, and pharmaceuticals, priced between $5,600 and $10,000 each. It also delivers bespoke custom market research engagements and operates proprietary databases (MasterFile Installed Base, ServiceTrak) for diagnostic equipment market intelligence, targeting IVD manufacturers, healthcare investors, and healthcare stakeholders globally.

Product overview

Kalorama Information, a brand of Science and Medicine Group, operates as a market intelligence and research firm specializing in life sciences. The portfolio consists of syndicated market reports (including In Vitro Diagnostics Business Outlook, 30-Country IVD Market Atlas, and Target Enrichment and Library Preparation for NGS reports), database products (MasterFile Installed Base), and consulting solutions (ServiceTrak, Custom Market Research, and strategic advisory services including Go to Market Strategy, Growth Opportunities, Market Landscape, Pricing Strategy, Product Development, Value Proposition, Branding, Competitive Assessment, and Customer Insights). The core offering centers on IVD and diagnostics market intelligence reports, supplemented by custom research services and strategic consulting solutions for top IVD manufacturers, investors, and healthcare stakeholders.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Market Research Tailored market research services designed to address specific business questions and strategic needs of clients in the life sciences and healthcare sectors, including market sizing, competitive assessment, and strategic consulting.
  • Market Reports Syndicated market intelligence reports providing industry analysis, market sizing, segmentation, and competitive insights across IVD, medical devices, biotechnology, and pharmaceuticals sectors, priced $5,600–$10,000.
  • MasterFile Installed Base Database Proprietary database tracking the installed base of laboratory and diagnostic equipment, providing detailed information on instrument placements and market penetration across healthcare facilities.
  • ServiceTrak Modality-specific service and satisfaction tracking for diagnostic instruments and equipment, providing insights into service contracts, maintenance, and support operations.
  • In Vitro Diagnostics Business Outlook, 2026 Annual syndicated market outlook report for the in vitro diagnostics industry covering disease detection, health monitoring, and treatment guidance applications.
  • 30-Country IVD Market Atlas, 2026 Comprehensive syndicated analysis of in vitro diagnostic markets across 30 key countries with detailed market sizing and 5-year forecasts tracking 18 IVD segments.
  • Target Enrichment and Library Preparation for Next-Generation Sequencing, 2026 Syndicated market report sizing the global NGS library preparation and target enrichment market through 2030, with competitive share estimates and profiles of leading suppliers.
  • Go to Market Strategy Strategic consulting service helping clients develop comprehensive market entry and expansion strategies supported by thorough market research.
  • Growth Opportunities Advisory service leveraging market research insights to identify and pursue growth opportunities within the life sciences and healthcare markets.
  • Market Landscape Analysis service providing essential market insights beyond extrapolated data to enhance projections and strategic decision-making.
  • Pricing Strategy Market research-driven pricing strategy service balancing profitability and perceived value for clients.
  • Product Development Strategic advisory service helping clients overcome product development hurdles and stay ahead of competitors using market research insights.
  • Value Proposition Service helping clients create compelling value propositions by understanding customer needs, preferences, and pain points through market research.
  • Branding Brand perception measurement service helping clients understand and measure intangible brand perceptions across diverse consumer segments for effective positioning.
  • Competitive Assessment Analysis service providing insights into competitors' strategies, market positioning, and customer perceptions to identify differentiation opportunities.
  • Customer Insights Feedback gathering service to drive informed decision-making and business success through essential customer feedback collection.

Quantifiable outcome

  • 5-year market forecasts for IVD segments across 30 countries
  • +1 more outcomes

Companies that use Kalorama Information

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Kalorama Information technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Kalorama Information partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Kalorama Information competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat3 records

Customer concentration

Kalorama Information social profiles

Digital presence

Kalorama Information financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kalorama Information leadership team

Management profile

Number of profiles

Kalorama Information funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kalorama Information M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kalorama Information

What does Kalorama Information do?

Kalorama Information publishes and sells syndicated market research reports covering in vitro diagnostics (IVD), medical devices, biotechnology, and pharmaceuticals, priced between $5,600 and $10,000 each. It also delivers bespoke custom market research engagements and operates proprietary databases (MasterFile Installed Base, ServiceTrak) for diagnostic equipment market intelligence, targeting IVD manufacturers, healthcare investors, and healthcare stakeholders globally.

Is Kalorama Information a public or private company?

Kalorama Information is a private company. It is classified as corporate owned and is currently operating.

When was Kalorama Information founded?

Kalorama Information was founded in 1998. It employs 1 to 10 people.

Where is Kalorama Information based?

Kalorama Information is headquartered in Arlington, United States, in the North America region.

How does Kalorama Information make money?

Two revenue lines are on record. Syndicated Market Reports are the primary driver. The others are custom Market Research.

Does Kalorama Information have an API?

No public API is recorded for Kalorama Information.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScienceandmedicinegroupIn Vitro Diagnostic (IVD) Trends and Market Update, 2025Kalorama Information released its December 2025 In Vitro Diagnostic (IVD) Trends and Market Update, providing critical insights into the evolving global IVD market amid economic uncertainties. The report highlights that the market continues to grow, driven by technological breakthroughs in next-generation sequencing and precision medicine, while also detailing competitive landscape shifts between major players like Abbott and Roche.ScienceandmedicinegroupCompanion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th EditionKalorama Information has published the fourth edition of its report on the global Companion Diagnostics (CDx) market, providing data-driven analysis and forecasts through 2029. The publication examines market trends, regulatory developments, and competitive landscapes involving key industry players such as Abbott, Roche, and Qiagen.ScienceandmedicinegroupWorldwide Market for Clinical Laboratory Services, 10th EditionKalorama Information has published the 10th edition of its market report on worldwide clinical laboratory services, providing an analysis of industry trends, market size, and competitive positioning from 2024 to 2029. The report highlights the transition of COVID-19 to endemic status as a key factor influencing diagnostic service dynamics and covers regional markets including North America, EMEA, and Asia Pacific. It also details specific strategic moves by major players such as Labcorp's acquisition of Invitae assets and Quest Diagnostics' new test launches.Kaloramainformationcell and gene therapy ReportsThe provided text is a collection of promotional listings for various market research reports published by Kalorama Information regarding the cell and gene therapy industry. These reports cover market dynamics, deal analysis, investment trends, and forecasts for the period between 2021 and 2031. The content serves as a catalog or aggregator page rather than a single news article reporting on a specific event.KaloramainformationDiagnostics Market ResearchKalorama Information is promoting its suite of market research reports covering the global in vitro diagnostics (IVD) and molecular diagnostics industries. The offerings include flagship annual studies, quarterly updates, and specialized atlases providing market sizing, forecasts through 2030, and competitive analysis for segments such as immunoassays and point-of-care testing. These publications target stakeholders seeking insights into industry trends, technological advancements, and growth opportunities within the healthcare diagnostics sector.ScienceandmedicinegroupThe World Market for Veterinary Diagnostics, 8th EditionThe veterinary diagnostics industry is experiencing significant growth driven by advancements in technology, increased pet ownership, and a rising need for disease control in livestock. Kalorama Information's report highlights key growth opportunities in the sector, projecting continued expansion through 2029. The market's segmentation indicates a strong demand for both companion animal and food animal diagnostics, emphasizing the importance of diagnostic testing in ensuring animal health and food safety.LigolabAutomation in Pathology Lab Management Using Advanced LIS System SoftwareThe article outlines the benefits and evolution of Laboratory Information Systems (LIS) in pathology labs, highlighting their role in automating workflows, improving accuracy, and reducing turnaround times. It cites market data from Kalorama Information projecting the LIS software market to reach $2.12 billion by 2025 and references LigoLab as a key provider with case studies demonstrating productivity gains for clients like ECPC.YahooRapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama ReportKalorama Information's report states the global point-of-care diagnostics market surpassed $36 billion in 2024, with growth projected through 2029. Abbott leads with over 25% share, and growth areas include oncology, stroke, and glucose monitoring. Innovations in CRISPR, AI, and wearables are expected to expand testing reach.PR NewswireRapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama ReportKalorama Information's report states the global point-of-care diagnostics market surpassed $36 billion in 2024, with mid-single-digit CAGR expected through 2029. Growth is driven by decentralization, innovation, and consumer demand, with Abbott leading at over 25% share.PR NewswireDiabetes Diagnostics Enters New Era: Kalorama Highlights Digital Shift and Global Surge in HbA1c TestingKalorama Information released a market study projecting the global HbA1c testing market to surpass $2.3 billion by 2029, growing at a 5.7% CAGR from its 2024 baseline of $1.7 billion, driven by decentralized point-of-care testing, mobile-connected analyzers, and AI-enabled chronic disease management tools.